Kodiak Sciences (KOD) Total Current Liabilities (2017 - 2026)
Kodiak Sciences (KOD) posted Total Current Liabilities of $49.6 million for Q1 2026, up 8.87% on a QoQ basis from $45.5 million in Q4 2025, and up 60.56% year-over-year from $30.9 million in Q1 2025.
Kodiak Sciences (KOD) Total Current Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $49.6 million for Q1 2026.
- Quarterly Total Current Liabilities rose 60.56% year-over-year to $49.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.6 million (up 60.56% YoY) and the FY2025 annual result came in at $45.5 million, up 78.05% from the prior year.
- Total Current Liabilities was $49.6 million for Q1 2026 at Kodiak Sciences, up from $45.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $76.3 million in Q1 2022 and bottomed at $21.2 million in Q2 2024.
- A 5-year average of $47.9 million and a median of $45.5 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 117.74% — and 2024, when it slumped 71.44%.
- Kodiak Sciences' Total Current Liabilities stood at $52.5 million in 2022, then dropped by 20.51% to $41.7 million in 2023, then tumbled by 38.72% to $25.6 million in 2024, then surged by 78.05% to $45.5 million in 2025, then advanced by 8.87% to $49.6 million in 2026.
- Business Quant data shows KOD's Total Current Liabilities at $49.6 million in Q1 2026, $45.5 million in Q4 2025, and $42.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 49.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.57 Mn |
| Dec 31, 2025 | 45.53 Mn |
| Sep 30, 2025 | 42.43 Mn |
| Jun 30, 2025 | 31.01 Mn |
| Mar 31, 2025 | 30.88 Mn |
| Dec 31, 2024 | 25.57 Mn |
| Sep 30, 2024 | 24.06 Mn |
| Jun 30, 2024 | 21.20 Mn |
| Mar 31, 2024 | 24.86 Mn |
| Dec 31, 2023 | 41.73 Mn |
| Sep 30, 2023 | 70.77 Mn |
| Jun 30, 2023 | 74.24 Mn |
| Mar 31, 2023 | 68.94 Mn |
| Dec 31, 2022 | 52.50 Mn |
| Sep 30, 2022 | 65.60 Mn |
| Jun 30, 2022 | 69.83 Mn |
| Mar 31, 2022 | 76.33 Mn |
| Dec 31, 2021 | 64.68 Mn |
| Sep 30, 2021 | 54.40 Mn |
| Jun 30, 2021 | 41.02 Mn |